We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NVX:NASDAQNOVONIX Limited - American Depository Shares Analysis

Data as of 2026-05-23 - not real-time

$0.69

Latest Price

8/10Risk

Risk Level: High

Executive Summary

NVX is trading at $0.69, well below its 20‑day (≈0.68) and 50‑day (≈0.71) SMAs, signaling a bearish price bias. The 200‑day SMA sits near $1.13, highlighting a long‑term downtrend. RSI hovers around 50, suggesting neither overbought nor oversold conditions. MACD line sits marginally under its signal, producing a bearish histogram. Volume has been increasing, confirming participation in the downside move. The stock is perched near its technical support at $0.589 and faces resistance around $0.76.
Volatility over the past 30 days exceeds 59%, and beta of 1.71 points to amplified market swings. The company’s fundamentals are distressed: operating margin is –9.2% and EBITDA is deeply negative. Cash burn continues with negative operating and free cash flow, while debt exceeds $100 million, yielding a debt‑to‑equity of 62%. Yet the price‑to‑book ratio under 1.0 and a price‑to‑sales of 26 suggest the market may be undervaluing the balance sheet. The Fear & Greed Index reads “Extreme Greed,” indicating speculative buying pressure despite weak fundamentals. Consequently, the stock presents a high‑risk, value‑oriented play that requires careful timing.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Bearish technical setup (price below SMAs, bearish MACD)
  • Proximity to support with high volatility
  • Negative earnings and cash flow

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential upside if battery market demand improves
  • High debt load limiting near‑term upside
  • Increasing volume indicating market interest

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Fundamental restructuring required for sustainable growth
  • Valuation appears cheap relative to book value
  • Continued regulatory and sector volatility

Key Metrics & Analysis

Financial Health

Revenue Growth-10.10%
P/E Ratio-3.0
ROE-61.97%
ROA-12.82%
Debt/Equity62.06
P/B Ratio0.9
Op. Cash Flow$-42199800
Free Cash Flow$-84516512
Industry P/E29.7

Technical Analysis

TrendBearish
RSI50.4
Support$0.59
Resistance$0.76
MA 20$0.68
MA 50$0.71
MA 200$1.13
MACDBearish
VolumeIncreasing
Fear & Greed Index91.61

Valuation

Target Price$4.00
Upside/Downside479.12%
GradeUndervalued
TypeValue

Risk Assessment

Beta1.71
Volatility59.09%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.